Azura Ophthalmics
Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD.
Total raised
€17M
€16,934,000
Funding rounds
1
Investors
4
distinct backers
Active since
2020-10
latest 2020-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood19
base rate 51% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-26 | Series C | €17M | Ganot Capital,Medical Research Commercialisation Fund (MRCF),OrbiMed,TPG Biotech | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Trax€791MIsrael · Software
- Oura Health€779MFinland · Healthtech